Who invested in GenomeDx Biosciences?
GenomeDx Biosciences's investors include Baird Capital, Aeris Capital, Merck Global Health Innovation Fund, CRG and CD-Venture.
Canada · Funded startup
3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 3 rounds since 2012, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by socaltech.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
GenomeDx Biosciences's investors include Baird Capital, Aeris Capital, Merck Global Health Innovation Fund, CRG and CD-Venture.
GenomeDx Biosciences has raised 3 rounds since 2012, none with a disclosed amount.
GenomeDx Biosciences's most recent round was a Debt in Sept 2015.
GenomeDx Biosciences's first round on record, in Jan 2012, was backed by Baird Capital and Aeris Capital.
GenomeDx Biosciences's latest named round is a Debt, in Sept 2015.
GenomeDx Biosciences is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.